Related by context. All words. (Click for frequent words.) 75 basal cell carcinoma BCC 72 prostate cancer CaP 72 squamous cell carcinoma SCC 71 histologic subtype 71 cutaneous squamous cell carcinoma 70 gastric adenocarcinoma 69 anterior uveitis 69 nonmetastatic 69 recurrent glioblastoma multiforme 69 bladder cancers 69 pancreatic adenocarcinoma 69 neoplasias 69 papillary renal cell carcinoma 68 nonmelanoma skin cancer 68 leiomyomas 68 node metastases 68 prostate adenocarcinoma 68 nonmelanoma skin cancers 68 solar keratosis 68 pheochromocytoma 68 Actinic Keratosis 68 urothelial carcinoma 68 prostate carcinoma 68 oesophageal adenocarcinoma 68 colorectal neoplasms 68 prostate cancer PCa 68 NMIBC 68 malignant pleural mesothelioma 68 colorectal carcinoma 68 operable breast cancer 68 renal tumors 67 advanced adenoma 67 leukemia AML 67 metastatic bladder 67 biliary tract cancer 67 Adenomas 67 Papillary 67 Malignant Melanoma 67 mycosis fungoides 67 hepatocellular carcinoma HCC 67 thymoma 67 thyroid carcinoma 67 HNSCC 67 skeletal metastases 67 esophageal squamous cell carcinoma 67 histologically confirmed 67 pT2 67 malignant neoplasm 67 metastatic gastric 67 Gorlin syndrome 67 intestinal metaplasia 67 colorectal adenoma 67 renal cell carcinomas 67 carcinoid tumor 67 cholangiocarcinoma 67 pT3 67 carcinoid tumors 67 nodal metastasis 67 PCa 67 neuroendocrine cancers 67 malignant neoplasms 67 Helicobacter pylori infection 67 urothelial cancer 66 metachronous 66 malignant lymphoma 66 metastatic malignant melanoma 66 advanced hepatocellular carcinoma 66 CP CPPS 66 GISTs 66 carotid stenosis 66 colorectal adenocarcinoma 66 CIN2 + 66 neoplastic lesions 66 cranial irradiation 66 bronchogenic carcinoma 66 nasopharyngeal carcinoma 66 basal cell carcinomas 66 endometrial hyperplasia 66 epithelial tumors 66 seminoma 66 urinary bladder cancer 66 transitional cell carcinoma 66 HGPIN 66 ADPKD 66 adenomatous polyps 66 adenomatous 66 grade cervical intraepithelial 66 metastatic malignant 66 testicular cancers 66 histological subtype 66 esophageal carcinoma 66 Glioblastoma Multiforme 66 mesotheliomas 66 gastric carcinoma 66 hematopoietic cancers 66 Candida infection 66 nonalcoholic steatohepatitis NASH 66 CIN3 66 Chronic lymphocytic leukemia 66 basal cell skin 65 neoplasia 65 epithelial ovarian 65 breast carcinoma 65 leukoencephalopathy 65 squamous cell lung cancer 65 T1a 65 paraganglioma 65 Endometrial 65 uveal melanoma 65 peritoneal cancer 65 MALT lymphoma 65 SSc 65 colorectal tumors 65 localized renal 65 tumors GIST 65 basal cell cancers 65 ductal carcinomas 65 unresectable tumors 65 lymphoproliferative disorders 65 metastatic GIST 65 papillary thyroid carcinoma 65 atrophic gastritis 65 oesophageal squamous cell carcinoma 65 BRCA mutation carriers 65 Glioblastoma Multiforme GBM 65 Surgical resection 65 hepatocellular carcinoma 65 precancerous cervical 65 invasive carcinomas 65 gastric cardia 65 recurrent metastatic 65 solar keratoses 65 vulvar intraepithelial neoplasia 65 FluCAM arm 65 radical prostatectomy RP 65 bacteriuria 65 completely resected 65 colorectal cancer CRC 65 epithelial ovarian cancer 65 cervical carcinoma 65 testicular tumors 65 CIN2 65 squamous cell cancers 65 superficial basal cell carcinoma 65 HBeAg negative 65 intraepithelial neoplasia 65 precursor lesions 65 chronic periodontitis 65 breast endometrial 64 nonsmall cell lung cancer 64 Hepatocellular Carcinoma HCC 64 lymphocytosis 64 ALA PDT 64 fallopian tube carcinoma 64 nodal metastases 64 surgically resectable 64 cervical intraepithelial neoplasia 64 cervical lesions 64 urothelial bladder cancer 64 recurrent glioblastoma multiforme GBM 64 geographic atrophy 64 situ CIS 64 squamous 64 lobular carcinoma 64 MGUS 64 T1c 64 relapsed MM 64 polyp recurrence 64 endometrial carcinoma 64 HER2 expression 64 choriocarcinoma 64 hepatorenal syndrome 64 severe oral mucositis 64 Basal Cell Carcinoma 64 biochemical relapse 64 papillary carcinoma 64 ASCUS 64 smoldering myeloma 64 liver metastasis 64 Adjuvant chemotherapy 64 basal cell nevus syndrome 64 pancreatic prostate 64 pulmonary metastases 64 idiopathic myelofibrosis 64 PCNSL 64 Waldenstrom macroglobulinemia 64 Squamous cell 64 PNET 64 nonmelanoma 64 mucinous 64 lymphomas leukemias 64 mRCC 64 pancreatic carcinoma 64 carcinoma 64 ductal breast cancer 64 invasive ductal 64 thymectomy 64 hyperplastic polyps 64 proliferative diabetic retinopathy 64 bullous 64 thyroid nodules 64 proliferative retinopathy 64 Sjögren syndrome 64 Leukemias 64 Langerhans cell histiocytosis 64 Cholangiocarcinoma 64 neovascularisation 64 metastatic renal cell carcinoma 64 Sezary syndrome 64 invasive candidiasis 64 peritoneal carcinomatosis 64 B Cell Lymphoma 64 locoregional recurrence 64 hepatocellular cancer 64 colorectal liver metastases 64 invasive lobular 64 metastatic colorectal 63 metastatic neuroendocrine tumors 63 lichen planus 63 SLNB 63 POAG 63 rectal cancers 63 leiomyosarcoma 63 Acute myeloid leukemia 63 gastrointestinal stromal tumors GIST 63 interstitial pneumonia 63 actinic keratosis 63 Carcinoma 63 follicular thyroid cancer 63 T1DM 63 differentiated thyroid 63 ocular toxicity 63 paragangliomas 63 polycythemia vera essential thrombocythemia 63 Squamous 63 Basal cell carcinoma 63 chronic rhinosinusitis 63 ovarian carcinoma 63 LHRH receptor positive 63 invasive carcinoma 63 pheochromocytomas 63 lobular cancer 63 Toxicities 63 gonococcal 63 follicular lymphoma FL 63 de novo AML 63 systemic scleroderma 63 lobular breast cancer 63 gastrointestinal stromal tumors GISTs 63 cell carcinomas 63 pleural mesothelioma 63 advanced adenomas 63 aplasia 63 pulmonary hypertension PH 63 Glioma 63 osteosarcomas 63 ovarian pancreatic 63 endometrial cancers 63 adenocarcinomas 63 gastrointestinal cancers 63 pulmonary metastasis 63 liver resection 63 extracapsular extension 63 primary hyperparathyroidism 63 metastatic pancreatic 63 HER2 overexpression 63 AA Amyloidosis 63 malignant lymphomas 63 cancerdefine 63 colorectum 63 Mitomycin C 63 GH deficiency 63 situ LCIS 63 subependymal giant cell 63 cell carcinoma 63 proctitis 63 cervical lymph node 63 metastatic lymph nodes 63 serous ovarian cancer 63 premalignant 63 polycythemia vera PV 63 BRCA deficient 63 diabetes mellitus DM 63 uterine tumors 63 bowel cancers 63 distant metastasis 63 renal scarring 63 adjuvant radiotherapy 63 hepatocellular carcinomas 63 acute myeloid 63 gastrointestinal stromal tumor 63 esophageal cancers 63 metastatic adenocarcinoma 63 dysplastic nevi 63 hyperplastic 63 hepatic metastases 63 rebleeding 63 Synovial sarcoma 63 CLL SLL 63 Bronchiectasis 63 ductal adenocarcinoma 63 HIV HCV coinfected 63 debulking surgery 63 recurrent NSCLC 63 pCR 63 papillary thyroid cancer 63 lymphoid malignancies 63 recurrent UTI 63 CC genotype 63 allogeneic HSCT 63 advanced neoplasia 62 oral squamous cell 62 LV dysfunction 62 actinic keratosis AK 62 neoplasms 62 Renal cell carcinoma 62 melanocytic nevi 62 recurrent VTE 62 nonalcoholic steatohepatitis 62 prostate carcinomas 62 abacavir Ziagen 62 candidemia 62 grade gliomas 62 Barrett esophagus BE 62 total thyroidectomy 62 FDG PET imaging 62 cytoreduction 62 EGFR mutation positive 62 stage IIIB 62 lung carcinomas 62 colorectal gastric 62 superficial bladder cancer 62 gastric cancers 62 ß blockers 62 artery stenosis 62 papillary 62 neoadjuvant treatment 62 deletion 5q 62 breast carcinomas 62 medullary thyroid cancer 62 malignant brain 62 biliary tract cancers 62 esophageal gastric 62 lymphocytic leukemia 62 resectable 62 postoperative AF 62 bladder ovarian 62 mCRPC 62 ductal cancer 62 myelodysplastic myeloproliferative diseases 62 leukemia ALL 62 Basal cell 62 cervical lymph nodes 62 Renal Cell Carcinoma RCC 62 invasive ductal carcinoma 62 external genital lesions 62 squamous cell carcinoma 62 bladder carcinoma 62 medullary thyroid carcinoma 62 bladder tumors 62 Heavy menstrual bleeding 62 confidence interval #.#-#.# 62 HER2 amplification 62 TT genotype 62 lymph node metastases 62 Endometrial cancer 62 SHPT 62 myelofibrosis MF 62 Legg Calvé Perthes disease 62 angiosarcoma 62 seminal vesicle invasion 62 symptomatic benign prostatic 62 vestibular schwannomas 62 malignancy 62 mitomycin C 62 HeFH 62 transthyretin amyloidosis 62 CYT# potent vascular disrupting 62 acute promyelocytic leukemia 62 FOLFIRI alone 62 reflux esophagitis 62 BRCA1 mutation carriers 62 baseline LDH 62 underwent resection 62 lupus erythematosus 62 histologically proven 62 Stage IIB 62 familial adenomatous polyposis FAP 62 recurrent venous thromboembolism 62 prostate cancer mCRPC 62 unresectable stage 62 recurrent malignant glioma 62 Adenocarcinoma 62 malignant polyps 62 immunocompetent 62 graft dysfunction 62 refractory prostate cancer 62 alpha1 antitrypsin deficiency 62 relapsing remitting MS RRMS 62 thromboembolic disease 62 relapsed ovarian cancer 62 hepatic fibrosis 62 KRAS mutations occur 62 autoantibody positive 62 cytomegalovirus infection 62 acute lymphoblastic 62 postoperative atrial fibrillation 62 cervical neoplasia 62 chlamydial infection 62 soft tissue sarcomas 62 inflammatory acne 62 adenocarcinoma 62 colorectal adenomas 62 Idiopathic Pulmonary Fibrosis 62 cisplatin chemotherapy 62 perimenopausal women 62 prostate cancer CRPC 61 Hurthle cell 61 radioiodine therapy 61 intraductal 61 myeloproliferative disorder 61 pre cancerous lesion 61 Follicular Lymphoma 61 visceral metastases 61 ANCA associated 61 K ras mutations 61 giant cell arteritis 61 BRAF mutations 61 Gleevec resistant 61 choroidal neovascularization 61 cell lymphoma CTCL 61 Chronic Myelogenous Leukemia CML 61 adenoma 61 abdominal irradiation 61 metaplasia 61 pancreatic neuroendocrine 61 medically inoperable 61 Acute Myeloid Leukaemia AML 61 mutated K ras 61 squamous cell cancer 61 bronchioloalveolar carcinoma 61 acne vulgaris 61 CTEPH 61 hyperparathyroidism 61 thrombocytopenic 61 flutamide 61 pelvic malignancies 61 acute leukemias 61 glioblastoma multiforme GBM 61 lung pancreatic 61 rectal carcinoma 61 Radiofrequency ablation 61 pelvic lymphadenectomy 61 neoplasm 61 Squamous Cell 61 symptomatic carotid stenosis 61 benign uterine 61 Basal Cell 61 metastatic basal cell 61 BRAF V#E 61 cytogenetic responses 61 invasive aspergillosis 61 papillomas 61 relapsed ALL 61 micrometastases 61 benign noncancerous 61 pancreatic lung 61 Prostatitis 61 adrenalectomy 61 castrate resistant prostate cancer 61 localized prostate 61 Uterine cancer 61 multicenter randomized controlled 61 multicentric 61 Squamous Cell Carcinoma 61 Non Alcoholic Fatty 61 allogeneic hematopoietic stem cell 61 Anaplastic 61 hepatitis C genotype 61 gastrointestinal stromal tumor GIST 61 Polycythemia vera 61 cisplatin resistant 61 polyposis 61 pleurodesis 61 myeloproliferative diseases 61 pretransplant 61 interstitial brachytherapy 61 essential thrombocythemia ET 61 venous blood clots 61 neuroendocrine tumors 61 Myelofibrosis 61 INCB# [003] 61 operable pancreatic cancer 61 vesicoureteral reflux VUR 61 colon tumors 61 Lymph node 61 purpura 61 PAOD 61 abnormal cytology 61 undergone radical prostatectomy 61 colorectal polyp 61 cytogenetic abnormalities 61 Liver transplantation 61 postoperative chemotherapy 61 Benign Prostatic Hyperplasia BPH 61 Prostatic 61 renal carcinoma 61 pituitary adenomas 61 vaginal lesions 61 cholelithiasis 61 ara C 61 kidney urologic 61 detecting precancerous 61 pancreatectomy 61 Nilotinib 61 chronic prostatitis 61 PSADT 61 sarcomatoid 61 spontaneous regression 61 Meningiomas 61 intralesional 61 immunopathology 61 chemoradiotherapy 61 ocular melanoma 61 HER2 positive cancers 61 gastroduodenal 61 malignant growths 61 recurrent colorectal cancer 61 Chlamydia trachomatis infection 61 histopathologic examination 61 Enlarged prostate 61 Neoplasms 61 Tyrosine Kinase Inhibitors 61 lung metastasis 61 tumor recurrence 61 treat benign prostatic 61 gene polymorphism 61 metastatic uveal melanoma 61 acute cholecystitis 61 castrate resistant 61 chemoradiation therapy 61 testicular germ cell 61 fibroadenomas 61 actinic keratoses 61 posttransplant 61 bile duct cancers 61 alemtuzumab treated 61 Metastatic breast cancer 61 seminomas 61 monoclonal anti 61 melanoma 61 relapsing multiple sclerosis 61 malignant melanomas 61 grade squamous intraepithelial 61 acute aortic dissection 61 chronic HBV infection 61 Radical prostatectomy 61 metastatic liver 61 neovascular 61 gastrointestinal perforation 61 pediatric malignancies 61 genital herpes infections 61 Nonalcoholic Fatty Liver Disease 61 mutated KRAS gene 61 hypereosinophilic syndrome 61 cutaneous lupus 61 atopic dermatitis AD 61 cervical dysplasia 61 hepatectomy 61 refractory anaplastic astrocytoma 61 % CI #.#-#.# [007] 61 severe neutropenia 61 metastatic lesions 61 precancerous condition 61 onset diabetes mellitus 61 GG genotype 61 Sentinel node biopsy 61 CMV infection 61 non resectable 61 hamartoma 61 premalignant lesions 61 anal lesions 61 postoperative morbidity 61 cerebral vasospasm 61 hyperhomocysteinemia 61 thromboembolic events 60 BRAF V#E mutation 60 hepatocellular 60 elevated LDH 60 squamous cell 60 pulmonary dysfunction 60 lymph node metastasis 60 immunocompetent patients 60 null responder 60 invasive lobular carcinoma 60 leucopenia 60 Staphylococcus aureus infections 60 Cystectomy 60 haematologic 60 chronic HBV 60 colorectal polyps 60 papular 60 Intravenous immunoglobulin 60 cinacalcet 60 liver transplant recipients 60 breast pancreatic 60 pre cancerous 60 thalidomide Thalomid 60 Diabetic nephropathy 60 symptomatic BPH 60 erythematosus 60 androgen ablation 60 anal cancers 60 cystectomy 60 Squamous cell carcinomas 60 secondary hyperparathyroidism 60 Metastases 60 atypical hyperplasia 60 paroxysmal AF 60 ertapenem 60 thrombocytosis 60 Adjuvant therapy 60 neurological manifestations 60 squamous cell carcinomas 60 idiopathic pulmonary arterial hypertension 60 urolithiasis 60 carcinoid 60 oropharyngeal cancer 60 bacillus Calmette Guerin 60 RAS mutations 60 vismodegib 60 gynecologic malignancy 60 desmoplastic 60 Angioedema 60 Doxil ® 60 benign prostatic hypertrophy 60 Acute Coronary Syndromes ACS 60 neoadjuvant therapy 60 varicella infection 60 prospective multicenter study 60 atypical ductal hyperplasia 60 tumoral 60 Melasma 60 metastatic lung cancer 60 systemic amyloidosis 60 MELAS 60 SGPT 60 repigmentation 60 tumor histology 60 malignant lesions 60 acute GvHD 60 hyperplasia BPH 60 malignant ascites 60 precancerous cervical lesions 60 benign prostatic hypertrophy BPH 60 axillary node 60 humanised monoclonal antibody 60 Asymptomatic 60 pancreatic ductal adenocarcinoma 60 nasopharyngeal cancer 60 anogenital warts 60 Myelodysplastic Syndrome MDS 60 deep venous thromboses 60 allograft rejection 60 leukemias lymphomas 60 CIN3 + 60 Colorectal 60 MGd 60 clinically localized prostate 60 EGFR HER2 60 Chronic Prostatitis 60 malignant fibrous histiocytoma 60 bone metastasis 60 microbial keratitis 60 PSA nadir 60 Hypotension 60 colorectal metastases 60 postoperative infection 60 Invasive Breast Cancer 60 Relapsing remitting MS 60 astrocytomas 60 ABCB1 60 malignant prostate 60 leukaemias 60 thyrotoxicosis 60 hypertrophic scars 60 perioperatively 60 Chronic Sinusitis 60 IDDM 60 NQO1 60 Microalbuminuria 60 leukoplakia 60 SJIA 60 carcinomas 60 receptor tyrosine kinase inhibitor 60 T2DM 60 recurrent GBM 60 anaplastic 60 skin cancers 60 ErbB2 positive 60 recurrent glioblastoma 60 pemphigus vulgaris 60 extracranial 60 colorectal cancer 60 IV NSCLC 60 metastatic ovarian cancer 60 systemic lupus erythematosus SLE 60 tuberous sclerosis TS 60 intracranial tumors 60 Androgenetic Alopecia 60 post transplant lymphoproliferative 60 Pemetrexed 60 aortic atherosclerosis 60 trans retinoic acid 60 premalignant lesion 60 systemic fungal infections 60 haematological cancers 60 Histological 60 cardiac dysfunction 60 pre cancerous actinic 60 cell lymphoma ALCL 60 coronary blockages 60 severe periodontitis 60 hyperoxaluria 60 transplantation HSCT 60 malignant melanoma 60 monoclonal gammopathy 60 cancerous enlargement 60 IPAH 60 contralateral breast 60 lung metastases 60 systemic lupus erythematosus 60 gastrointestinal GI cancers 60 neoplastic cells 60 essential thrombocythemia 60 liposomal amphotericin B 60 radical nephrectomy 60 complete cytogenetic response 60 prostatic hyperplasia 60 parathyroidectomy 60 squamous carcinoma 60 poorer prognosis 60 TTR amyloidosis 60 undergoing radical prostatectomy 60 lung adenocarcinomas 60 Hematologic 60 perioperative morbidity 60 Herpes zoster 60 nutlin 3a 60 chronic thromboembolic pulmonary 60 torsade de pointes 60 Her2 positive 60 IV melanoma 60 atopic asthma 60 gonococcal infection 60 antiphospholipid antibodies 60 patients undergoing CABG 60 adjuvant therapies 60 Testicular cancer 60 metastatic kidney 60 chronic idiopathic thrombocytopenic purpura 60 infiltrating ductal carcinoma 60 neoplasia CIN 60 Myelodysplastic syndromes MDS 60 elevated triglyceride levels 60 fallopian tube cancers 60 esophageal tumors 60 nephrotoxicity 60 clinicopathological 60 Vidaza azacitidine 60 neoadjuvant chemotherapy 60 hematologic toxicity 60 recurrent genital herpes 60 androgen suppression 60 gallstone disease 60 ovarian malignancy 60 neuroblastoma tumors 60 adenoma recurrence 60 hepatic cirrhosis 60 lymphadenectomy 60 cirrhotic 60 Soft Tissue Sarcoma 60 β blockers 60 neovascular diseases 60 GSTT1 60 radiofrequency ablation RFA 60 distant metastases 60 resectable pancreatic cancer 60 Ischemic 60 Hepatocellular Carcinoma 60 seropositivity 60 chronic urticaria 60 atherothrombotic 60 Lymphomas 60 STRIDE PD 60 bronchial hyperresponsiveness 60 Carcinomas 60 chlamydial 60 pulmonary resection 60 atrophic vaginitis 60 pre cancerous growths 60 neuroblastoma tumor 60 hydronephrosis 60 acromegalic patients 60 stage IIIb IV 60 Epstein Barr virus EBV 60 Sjogren Syndrome 60 polypoid 60 heavily pretreated 60 atherothrombosis 60 taxane resistant 60 Flu Cy 60 gefitinib Iressa 60 fibroma 60 Venous thromboembolism 60 stratifying patients 60 liver metastases 60 dysmenorrhoea 60 renal transplantation 60 oral leukoplakia 60 hepatoma 60 assessing T DM1 60 infective endocarditis 60 myeloproliferative neoplasms 60 chronic eosinophilic leukemia 60 intestinal polyps 60 C. trachomatis 60 Circulating tumor cells 60 prognostic variables 60 androgenetic alopecia 60 Brain metastases 60 BCG refractory 59 metastatic prostate cancer 59 metastatic renal 59 multimodality therapy 59 Digital Mammographic Imaging 59 elevated ALT 59 fibrosing 59 Cutaneous T 59 Gastric cancer 59 Duodenal 59 octreotide LAR 59 elevated transaminases 59 duplex ultrasonography 59 clinically detectable 59 euthyroid 59 MYCN amplification 59 F FDG PET 59 cytologic 59 anti angiogenic therapy 59 TKI therapy 59 curative resection 59 leiomyoma 59 pancreatic neuroendocrine tumors 59 de ath 59 MAGE A3 ASCI 59 type 1diabetes 59 lobular carcinomas 59 macroalbuminuria 59 Ductal Carcinoma 59 hypovitaminosis D 59 recurrent DVT 59 endometrioid 59 cytoreductive surgery 59 nonproliferative 59 invasive fungal infection 59 micrometastasis 59 locoregional 59 Systemic Lupus Erythematosus SLE 59 perianal 59 EoE 59 hormone refractory metastatic prostate 59 ankylosing spondylitis AS 59 intracranial hemorrhage ICH 59 Medullary thyroid cancer 59 lentigo maligna 59 Ascites 59 Malignant glioma 59 dysglycemia 59 esophagogastric 59 atopic disease 59 cancers 59 Non Alcoholic Steatohepatitis 59 Overactive Bladder OAB 59 progesterone receptor negative 59 abnormal uterine bleeding 59 neovascular AMD 59 extranodal 59 colon adenomas 59 #F FDG PET 59 lymph node involvement 59 lung colorectal 59 Hodgkin lymphoma HL 59 galiximab 59 PsA 59 malignant pancreatic 59 receiving highly emetogenic 59 autologous SCT 59 simplex virus 59 refractory acute myeloid 59 resistant hormone refractory 59 acute myelogenous leukemia AML 59 invasive cervical cancer 59 pediatric acute lymphoblastic 59 neurofibromas 59 noncardiac 59 LVNC 59 S aureus 59 Hurler syndrome 59 % CI #.#-#.# [008] 59 FDG-PET/CT 59 keloid scars 59 bilateral oophorectomy 59 hematologic abnormalities 59 pain palliation 59 Accelerated Partial Breast Irradiation 59 enterococcal 59 Keratitis 59 mCRC patients 59 lymphoproliferative disease 59 Colon polyps 59 metastatic RCC 59 Gliomas 59 platinum refractory 59 hormone receptor status 59 BARACLUDE ® 59 renal cell carcinoma 59 autonomic dysfunction 59 ALT elevation 59 gastroesophageal reflux GERD 59 transarterial 59 refractory colorectal cancer 59 colorectal pancreatic 59 antitumor effect 59 diabetic peripheral neuropathy DPN 59 diffuse intrinsic pontine glioma 59 Aortic stenosis 59 keratoses 59 occlusive disease 59 computed tomography angiography 59 prostate ovarian 59 bronchoalveolar lavage 59 Lymphocytic 59 CTAP# 59 Mohs micrographic surgery 59 orchitis 59 KRAS mutant tumors 59 chronic GVHD 59 glucocorticoid induced osteoporosis 59 malignant pleural effusion 59 CR CRu 59 spontaneous bacterial peritonitis 59 pancreatic cancers 59 antibody titer 59 hamartomas 59 intravesical chemotherapy 59 nodular melanoma 59 chronically immunosuppressed solid 59 ZACTIMA 59 cervical vaginal 59 psoriatic arthritis PsA 59 serum urate levels 59 Thromboembolism 59 CIMZIA TM certolizumab pegol 59 chemoresistant 59 spinal metastases 59 Urinary tract 59 idiopathic pulmonary 59 Stomatitis 59 mediastinitis 59 non splenectomized 59 urethritis 59 melanoma lesions 59 superficial basal cell carcinomas 59 postoperative pulmonary 59 underlying vasculopathy 59 Retreatment 59 anaplastic astrocytoma 59 atherosclerotic renal artery stenosis 59 chorioamnionitis 59 ano genital warts 59 Cell Lymphoma 59 minimally symptomatic 59 myeloid leukemia 59 CRVO 59 recurrent myocardial infarction 59 relapsed leukemia 59 varicocele 59 androgen deprivation 59 ocular disorders 59 underwent surgical resection 59 neuroendocrine carcinoma 59 renal pelvis 59 antiangiogenic therapy 59 hormone receptor negative 59 pre cancerous lesions 59 endometrial tumors 59 Enzastaurin 59 node dissection